Corrigendum to "How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain": [ESMO Open, 7 (2022) 100462]

ESMO Open. 2022 Jun;7(3):100504. doi: 10.1016/j.esmoop.2022.100504. Epub 2022 May 26.

Authors

A Castañeda¹, M Gorostegui¹, S L Miralles¹, A Chamizo¹, S C Patiño¹, M A Flores¹, M Garraus¹, J J Lazaro¹, V Santa-Maria¹, A Varo¹, J P Muñoz¹, J Mora²

Affiliations

¹ Sant Joan de Déu Barcelona Children's Hospital, Barcelona, Spain.
² Sant Joan de Déu Barcelona Children's Hospital, Barcelona, Spain. Electronic address: jaume.mora@sjd.es.

No abstract available

Publication types

Published Erratum